Amgen Aims To Add A New Title: Biosimilar Star Player
Executive Summary
Amgen will leverage its strength in biologics as it moves into the burgeoning biosimilar drug market. Its manufacturing capability could provide a leg up versus rivals, and the company showcased its expertise on a recent tour of its Rhode Island biologics manufacturing facility.